Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Coutant

Showing results (81-90 of 189) with videos related to

Pageof 19
Sort By:
British Journal of Cancer|November 9, 2016
Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study groupLobna Ouldamer, Sofiane Bendifallah, Gilles Body, et al.
Annals of Surgical Oncology|January 8, 2015
French Multicenter Study Evaluating the Risk of Lymph Node Metastases in Early-Stage Endometrial Cancer: Contribution of a Risk Scoring SystemSofiane Bendifallah, Geoffroy Canlorbe, Emmanuelle Arsène, et al.
Breast (Edinburgh, Scotland)|June 26, 2021
Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-studyAriane Mamguem Kamga, Oumar Billa, Sylvain Ladoire, et al.
Breast Cancer Research and Treatment|May 6, 2025
How can we optimize the surgical management of the axilla in breast cancer since the MonarchE trial?Clémentine Jankowski, Gilles Houvenaeghel, Celine Renaudeau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2015
Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast CancerOlivier Humbert, Jean-Marc Riedinger, Céline Charon-Barra, et al.
Cancers|June 18, 2020
What Are Young Women Living Conditions after Breast Cancer? Health-Related Quality of Life, Sexual and Fertility Issues, Professional ReinsertionEmerline L F Assogba, Ariane Mamguem Kamga, Helène Costaz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2013
¹⁸F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorationsAlexandre Cochet, Inna Dygai-Cochet, Jean-Marc Riedinger, et al.
Annals of Surgical Oncology|May 9, 2015
Tumor Size, an Additional Prognostic Factor to Include in Low-Risk Endometrial Cancer: Results of a French Multicenter StudyGeoffroy Canlorbe, Sofiane Bendifallah, Enora Laas, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 7, 2019
Incidence, patterns and prognosis of first distant recurrence after surgically treated early stage endometrial cancer: Results from the multicentre FRANCOGYN study groupLobna Ouldamer, Sofiane Bendifallah, Gilles Body, et al.
European Journal of Cancer Care|March 28, 2020
Socio-economic and occupational outcomes of long-term survivors of gynaecological cancer: A French population-based studyAriane Mamguem Kamga, Agnès Dumas, Florence Joly, et al.
Pageof 19

Showing results (81-90 of 189) with videos related to

Sort By:
Pageof 19
British Journal of Cancer|November 9, 2016
Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study groupLobna Ouldamer, Sofiane Bendifallah, Gilles Body, et al.
Annals of Surgical Oncology|January 8, 2015
French Multicenter Study Evaluating the Risk of Lymph Node Metastases in Early-Stage Endometrial Cancer: Contribution of a Risk Scoring SystemSofiane Bendifallah, Geoffroy Canlorbe, Emmanuelle Arsène, et al.
Breast (Edinburgh, Scotland)|June 26, 2021
Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-studyAriane Mamguem Kamga, Oumar Billa, Sylvain Ladoire, et al.
Breast Cancer Research and Treatment|May 6, 2025
How can we optimize the surgical management of the axilla in breast cancer since the MonarchE trial?Clémentine Jankowski, Gilles Houvenaeghel, Celine Renaudeau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2015
Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast CancerOlivier Humbert, Jean-Marc Riedinger, Céline Charon-Barra, et al.
Cancers|June 18, 2020
What Are Young Women Living Conditions after Breast Cancer? Health-Related Quality of Life, Sexual and Fertility Issues, Professional ReinsertionEmerline L F Assogba, Ariane Mamguem Kamga, Helène Costaz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2013
¹⁸F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorationsAlexandre Cochet, Inna Dygai-Cochet, Jean-Marc Riedinger, et al.
Annals of Surgical Oncology|May 9, 2015
Tumor Size, an Additional Prognostic Factor to Include in Low-Risk Endometrial Cancer: Results of a French Multicenter StudyGeoffroy Canlorbe, Sofiane Bendifallah, Enora Laas, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 7, 2019
Incidence, patterns and prognosis of first distant recurrence after surgically treated early stage endometrial cancer: Results from the multicentre FRANCOGYN study groupLobna Ouldamer, Sofiane Bendifallah, Gilles Body, et al.
European Journal of Cancer Care|March 28, 2020
Socio-economic and occupational outcomes of long-term survivors of gynaecological cancer: A French population-based studyAriane Mamguem Kamga, Agnès Dumas, Florence Joly, et al.
Pageof 19